TABLE 4.
No. | Study site | Farm code | Isolate code | Type of sample | Serotype | Resistance pattern |
---|---|---|---|---|---|---|
1 | Adama | APF1 | AP 10 | Feces | Give | Fm |
2 | Adama | APF1 | AP 12 | Feces | Give | Fm |
3 | Adama | APF4 | AP 58 | Feces | Haifa | K, S, Te |
4 | Adama | APF7 | AP 89 | Feces | Haifa | K, S, Te |
5 | Adama | APF7 | AP 96 | Feces | Haifa | N, Fm, S, Te |
6 | Adama | APF9 | AP 112 | Feces | Haifa | K, S, Te |
7 | Adama | APF10 | AP 122 | Feces | Anatum | S, Su, Te |
8 | Adama | APF10 | AP 124 | Feces | Anatum | S, Su, Te |
9 | Adama | APF11 | AP 140 | Feces | Haifa | N, Fm, S, Su, Te |
10 | Adama | APF11 | AP 141 | Feces | Haifa | S, Te |
11 | Adama | APF12 | AP 153 | Feces | Haifa | S, Su, Te |
12 | Adama | APF13 | AP 161 | Feces | Haifa | S, Te |
13 | Adama | APF13 | AP 162 | Feces | Haifa | N, Fm, S, Te |
14 | Adama | APF14 | AP 170 | Feces | Haifa | N, Fm, S, Te |
15 | Adama | APF17 | AP 196 | CS | Anatum | Fm, S, Su |
16 | Adama | APF19 | AP 218 | Feces | Haifa | N, Fm, S, Te |
17 | Adama | APF22 | AP 233 | Feces | Give | Fm |
18 | Adama | APF23 | AP 262 | Feces | Give | Fm |
19 | Adama | APF10 | AH 04 | Stool | Anatum | Fm, S, Su, Te |
20 | Adama | APF7 | Fl 7 | Fl | Haifa | S, Te |
21 | Adama | APF14 | Fl 14 | Fl | Haifa | S, Te |
22 | Modjo | MPF19 | MP 192 | Feces | Anatum | S |
23 | Modjo | MPF31 | MP 374 | Feces | Anatum | S, Su, Te |
24 | Modjo | MPF33 | MP410 | Feces | Anatum | N, S, Su, Te |
25 | Modjo | MPF18 | MP 191 | Feces | Haifa | Te |
Amp = ampicillin, Cf = cephalothin, Cro = ceftriaxone, Cip = ciprofloxacin, Gm = gentamicin, K = kanamycin, Tmp = trimethoprim, S = Streptomycin, Sxt = sulfamethoxazole+trimethoprim, Te = tetracycline, Su = sulfisoxazole, Fm = nitrofurantoin, Na = nalidixic acid, N = neomycin; CS = cloacal swab, Fl = floor swab.